Articoli di riviste sul tema "Broadly neutralizing antibodies (bNAbs)"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Broadly neutralizing antibodies (bNAbs)".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Karuna, Shelly T., e Lawrence Corey. "Broadly Neutralizing Antibodies for HIV Prevention". Annual Review of Medicine 71, n. 1 (27 gennaio 2020): 329–46. http://dx.doi.org/10.1146/annurev-med-110118-045506.
Testo completoYang, Guang, Mengfei Liu, Kevin Wiehe, Nathan Nicely, Barton Haynes, John Mascola, Pamela Bjorkman e Garnett Kelsoe. "HIV broadly neutralizing antibodies and immunological tolerance (VAC7P.988)". Journal of Immunology 192, n. 1_Supplement (1 maggio 2014): 141.33. http://dx.doi.org/10.4049/jimmunol.192.supp.141.33.
Testo completoLubow, Jay, Lisa M. Levoir, Duncan K. Ralph, Laura Belmont, Maya Contreras, Catiana H. Cartwright-Acar, Caroline Kikawa et al. "Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses". PLOS Pathogens 19, n. 10 (9 ottobre 2023): e1011722. http://dx.doi.org/10.1371/journal.ppat.1011722.
Testo completoSprenger, Kayla G., Joy E. Louveau, Pranav M. Murugan e Arup K. Chakraborty. "Optimizing immunization protocols to elicit broadly neutralizing antibodies". Proceedings of the National Academy of Sciences 117, n. 33 (3 agosto 2020): 20077–87. http://dx.doi.org/10.1073/pnas.1919329117.
Testo completoGlazkova, D. V., E. V. Bogoslovskaya, G. A. Shipulin e S. M. Yudin. "Broadly neutralizing antibodies for the treatment of HIV infection". HIV Infection and Immunosuppressive Disorders 13, n. 3 (24 ottobre 2021): 81–95. http://dx.doi.org/10.22328/2077-9828-2021-13-3-81-95.
Testo completoShrader, Hannah, Sabrina Helmold Hait, Sarah Lovelace, Meaghan Kilner, Chen-Hsiang Shen, Emily Coates, Martin Gaudinski et al. "Phenotypic analysis of HIV-1 resistance to CD4 binding site broadly-neutralizing antibodies". Journal of Immunology 210, n. 1_Supplement (1 maggio 2023): 223.08. http://dx.doi.org/10.4049/jimmunol.210.supp.223.08.
Testo completoSteichen, Jon M., Ying-Cing Lin, Colin Havenar-Daughton, Simone Pecetta, Gabriel Ozorowski, Jordan R. Willis, Laura Toy et al. "A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses". Science 366, n. 6470 (31 ottobre 2019): eaax4380. http://dx.doi.org/10.1126/science.aax4380.
Testo completoThavarajah, Jannifer Jasmin, Bo Langhoff Hønge e Christian Morberg Wejse. "The Use of Broadly Neutralizing Antibodies (bNAbs) in HIV-1 Treatment and Prevention". Viruses 16, n. 6 (4 giugno 2024): 911. http://dx.doi.org/10.3390/v16060911.
Testo completoKumar, Rajesh, Huma Qureshi, Suprit Deshpande e Jayanta Bhattacharya. "Broadly neutralizing antibodies in HIV-1 treatment and prevention". Therapeutic Advances in Vaccines and Immunotherapy 6, n. 4 (agosto 2018): 61–68. http://dx.doi.org/10.1177/2515135518800689.
Testo completoXu, Ling, Amarendra Pegu, Ercole Rao, Nicole Doria-Rose, Jochen Beninga, Krisha McKee, Dana M. Lord et al. "Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques". Science 358, n. 6359 (20 settembre 2017): 85–90. http://dx.doi.org/10.1126/science.aan8630.
Testo completoMayer, Bryan T., Allan C. deCamp, Yunda Huang, Joshua T. Schiffer, Raphael Gottardo, Peter B. Gilbert e Daniel B. Reeves. "Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention". PLOS Computational Biology 18, n. 4 (6 aprile 2022): e1010003. http://dx.doi.org/10.1371/journal.pcbi.1010003.
Testo completoKhurana, Surender, Megan Hahn, Laura Klenow e Hana Golding. "Autoreactivity of Broadly Neutralizing Influenza Human Antibodies to Human Tissues and Human Proteins". Viruses 12, n. 10 (8 ottobre 2020): 1140. http://dx.doi.org/10.3390/v12101140.
Testo completoSmith, S. Abigail, e Cynthia A. Derdeyn. "Harnessing the protective potential of HIV-1 neutralizing antibodies". F1000Research 5 (5 gennaio 2016): 20. http://dx.doi.org/10.12688/f1000research.7254.1.
Testo completoMishra, Nitesh, Sanjeev Kumar, Swarandeep Singh, Tanu Bansal, Nishkarsh Jain, Sumedha Saluja, Rajesh Kumar et al. "Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma". PLOS Pathogens 17, n. 9 (24 settembre 2021): e1009958. http://dx.doi.org/10.1371/journal.ppat.1009958.
Testo completoMcGuire, Andrew T., Sam Hoot, Anita M. Dreyer, Adriana Lippy, Andrew Stuart, Kristen W. Cohen, Joseph Jardine et al. "Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies". Journal of Experimental Medicine 210, n. 4 (25 marzo 2013): 655–63. http://dx.doi.org/10.1084/jem.20122824.
Testo completoMedina-Ramírez, Max, Fernando Garces, Amelia Escolano, Patrick Skog, Steven W. de Taeye, Ivan Del Moral-Sanchez, Andrew T. McGuire et al. "Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo". Journal of Experimental Medicine 214, n. 9 (28 agosto 2017): 2573–90. http://dx.doi.org/10.1084/jem.20161160.
Testo completoAn, Zhiyin, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan e Yingjie Xu. "The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice". Pharmaceutics 15, n. 5 (5 maggio 2023): 1412. http://dx.doi.org/10.3390/pharmaceutics15051412.
Testo completoNoailly, Blandine, Melyssa Yaugel-Novoa, Justine Werquin, Fabienne Jospin, Daniel Drocourt, Thomas Bourlet, Nicolas Rochereau e Stéphane Paul. "Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent". Vaccines 10, n. 6 (6 giugno 2022): 903. http://dx.doi.org/10.3390/vaccines10060903.
Testo completoCaillat, Christophe, Delphine Guilligay, Guidenn Sulbaran e Winfried Weissenhorn. "Neutralizing Antibodies Targeting HIV-1 gp41". Viruses 12, n. 11 (23 ottobre 2020): 1210. http://dx.doi.org/10.3390/v12111210.
Testo completoSakoi-Mosetlhi, Maureen, Gbolahan Ajibola, Roxanna Haghighat, Oganne Batlang, Kenneth Maswabi, Molly Pretorius-Holme, Kathleen M. Powis et al. "Caregivers of children with HIV in Botswana prefer monthly IV Broadly Neutralizing Antibodies (bNAbs) to daily oral ART". PLOS ONE 19, n. 3 (27 marzo 2024): e0299942. http://dx.doi.org/10.1371/journal.pone.0299942.
Testo completoWasilewski, Lisa N., Ramy El-Diwany, Supriya Munshaw, Anna E. Snider, Jillian K. Brady, William O. Osburn, Stuart C. Ray e Justin R. Bailey. "A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies". Journal of Virology 90, n. 7 (27 gennaio 2016): 3773–82. http://dx.doi.org/10.1128/jvi.02837-15.
Testo completoStephenson, Kathryn E., Kshitij Wagh, Bette Korber e Dan H. Barouch. "Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention". Annual Review of Immunology 38, n. 1 (26 aprile 2020): 673–703. http://dx.doi.org/10.1146/annurev-immunol-080219-023629.
Testo completoAli, Ayub, Scott G. Kitchen, Irvin S. Y. Chen, Hwee L. Ng, Jerome A. Zack e Otto O. Yang. "HIV-1-Specific Chimeric Antigen Receptors Based on Broadly Neutralizing Antibodies". Journal of Virology 90, n. 15 (25 maggio 2016): 6999–7006. http://dx.doi.org/10.1128/jvi.00805-16.
Testo completoWelles, Hugh C., Hannah A. D. King, Leonard Nettey, Nicole Cavett, Jason Gorman, Tongqing Zhou, Yaroslav Tsybovsky et al. "Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4". PLOS Pathogens 18, n. 6 (16 giugno 2022): e1010574. http://dx.doi.org/10.1371/journal.ppat.1010574.
Testo completoBrinkkemper, Mitch, e Kwinten Sliepen. "Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies". Vaccines 7, n. 3 (29 luglio 2019): 76. http://dx.doi.org/10.3390/vaccines7030076.
Testo completoKlein, Florian, Lilian Nogueira, Yoshiaki Nishimura, Ganesh Phad, Anthony P. West, Ariel Halper-Stromberg, Joshua A. Horwitz et al. "Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants". Journal of Experimental Medicine 211, n. 12 (10 novembre 2014): 2361–72. http://dx.doi.org/10.1084/jem.20141050.
Testo completoLingwood, Daniel. "Natural gene-encoded affinity for cognate antigen facilitates vaccine-amplification of broadly neutralizing antibodies against influenza virus". Journal of Immunology 202, n. 1_Supplement (1 maggio 2019): 139.22. http://dx.doi.org/10.4049/jimmunol.202.supp.139.22.
Testo completoDoores, Katie J., Leopold Kong, Stefanie A. Krumm, Khoa M. Le, Devin Sok, Uri Laserson, Fernando Garces, Pascal Poignard, Ian A. Wilson e Dennis R. Burton. "Two Classes of Broadly Neutralizing Antibodies within a Single Lineage Directed to the High-Mannose Patch of HIV Envelope". Journal of Virology 89, n. 2 (5 novembre 2014): 1105–18. http://dx.doi.org/10.1128/jvi.02905-14.
Testo completoShcherbakov, D. N., A. Yu Bakulina, L. I. Karpenko e A. A. Ilyichev. "Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response". Acta Naturae 7, n. 4 (15 dicembre 2015): 11–21. http://dx.doi.org/10.32607/20758251-2015-7-4-11-21.
Testo completoBiswas, Mrityunjoy, Tatsuya Yamazaki, Joe Chiba e Sachiko Akashi-Takamura. "Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination". Vaccines 8, n. 3 (29 luglio 2020): 424. http://dx.doi.org/10.3390/vaccines8030424.
Testo completoWang, Qian, e Linqi Zhang. "Broadly neutralizing antibodies and vaccine design against HIV-1 infection". Frontiers of Medicine 14, n. 1 (19 dicembre 2019): 30–42. http://dx.doi.org/10.1007/s11684-019-0721-9.
Testo completoDoria-Rose, Nicole A., Jinal N. Bhiman, Ryan S. Roark, Chaim A. Schramm, Jason Gorman, Gwo-Yu Chuang, Marie Pancera et al. "New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency". Journal of Virology 90, n. 1 (14 ottobre 2015): 76–91. http://dx.doi.org/10.1128/jvi.01791-15.
Testo completovan Dongen, Maria J. P., Rameshwar U. Kadam, Jarek Juraszek, Edward Lawson, Boerries Brandenburg, Frederike Schmitz, Wim B. G. Schepens et al. "A small-molecule fusion inhibitor of influenza virus is orally active in mice". Science 363, n. 6431 (7 marzo 2019): eaar6221. http://dx.doi.org/10.1126/science.aar6221.
Testo completoMalbec, Marine, Françoise Porrot, Rejane Rua, Joshua Horwitz, Florian Klein, Ari Halper-Stromberg, Johannes F. Scheid et al. "Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission". Journal of Experimental Medicine 210, n. 13 (25 novembre 2013): 2813–21. http://dx.doi.org/10.1084/jem.20131244.
Testo completoTian, Ming, Kelly McGovern, Hwei-Ling Cheng, Peyton Waddicor, Lisa Rieble, Mai Dao, Yiwei Chen et al. "Conditional antibody expression to avoid central B cell deletion in humanized HIV-1 vaccine mouse models". Proceedings of the National Academy of Sciences 117, n. 14 (24 marzo 2020): 7929–40. http://dx.doi.org/10.1073/pnas.1921996117.
Testo completoVanderVeen, Laurie A., Lisa Selzer, Brian Moldt, Aiyappa Parvangada, Jiani Li, Jintanat Ananworanich, Trevor A. Crowell et al. "HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection". AIDS 38, n. 4 (16 novembre 2023): 607–10. http://dx.doi.org/10.1097/qad.0000000000003792.
Testo completoLiu, Mengfei, Guang Yang, Kevin Wiehe, Nathan I. Nicely, Nathan A. Vandergrift, Wes Rountree, Mattia Bonsignori et al. "Polyreactivity and Autoreactivity among HIV-1 Antibodies". Journal of Virology 89, n. 1 (29 ottobre 2014): 784–98. http://dx.doi.org/10.1128/jvi.02378-14.
Testo completoDiLillo, David, Gene Tan, Peter Palese e Jeffrey Ravetch. "Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo (VAC6P.951)". Journal of Immunology 192, n. 1_Supplement (1 maggio 2014): 140.12. http://dx.doi.org/10.4049/jimmunol.192.supp.140.12.
Testo completoMkhize, Nonhlanhla N., Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume, David Matten et al. "Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials". PLOS Pathogens 19, n. 6 (29 giugno 2023): e1011469. http://dx.doi.org/10.1371/journal.ppat.1011469.
Testo completoSwann, Rachael E., Vanessa M. Cowton, Mark W. Robinson, Sarah J. Cole, Stephen T. Barclay, Peter R. Mills, Emma C. Thomson, John McLauchlan e Arvind H. Patel. "Broad Anti-Hepatitis C Virus (HCV) Antibody Responses Are Associated with Improved Clinical Disease Parameters in Chronic HCV Infection". Journal of Virology 90, n. 9 (24 febbraio 2016): 4530–43. http://dx.doi.org/10.1128/jvi.02669-15.
Testo completoMankowski, Madeleine C., Valerie J. Kinchen, Lisa N. Wasilewski, Andrew I. Flyak, Stuart C. Ray, James E. Crowe e Justin R. Bailey. "Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms". Proceedings of the National Academy of Sciences 115, n. 1 (18 dicembre 2017): E82—E91. http://dx.doi.org/10.1073/pnas.1718441115.
Testo completoWalsh, Stephen R., e Michael S. Seaman. "Broadly Neutralizing Antibodies for HIV-1 Prevention". Frontiers in Immunology 12 (20 luglio 2021). http://dx.doi.org/10.3389/fimmu.2021.712122.
Testo completoLorenzi, Julio C. C., Pilar Mendoza, Yehuda Z. Cohen, Lilian Nogueira, Christy Lavine, Joseph Sapiente, Marie Wiatr et al. "Neutralizing Activity of Broadly Neutralizing anti-HIV-1 Antibodies against Primary African Isolates". Journal of Virology, 9 dicembre 2020. http://dx.doi.org/10.1128/jvi.01909-20.
Testo completoAnthony, Colin, Talita York, Valerie Bekker, David Matten, Philippe Selhorst, Roux-Cil Ferreria, Nigel J. Garrett et al. "Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope". Journal of Virology 91, n. 18 (5 luglio 2017). http://dx.doi.org/10.1128/jvi.00828-17.
Testo completoWaters, Laura, Rosa de Miguel-Buckley, Sébastien Poulin e Jose R. Arribas. "Broadly Neutralizing Antibodies for HIV Treatment: Broad in Theory, Narrow in Reality". Clinical Infectious Diseases, 28 ottobre 2022. http://dx.doi.org/10.1093/cid/ciac835.
Testo completoLeggat, David J., Kristen W. Cohen, Jordan R. Willis, William J. Fulp, Allan C. deCamp, Oleksandr Kalyuzhniy, Christopher A. Cottrell et al. "Vaccination induces HIV broadly neutralizing antibody precursors in humans". Science 378, n. 6623 (2 dicembre 2022). http://dx.doi.org/10.1126/science.add6502.
Testo completoSchiffner, Torben, Ivy Phung, Rashmi Ray, Adriana Irimia, Ming Tian, Olivia Swanson, Jeong Hyun Lee et al. "Vaccination induces broadly neutralizing antibody precursors to HIV gp41". Nature Immunology, 30 maggio 2024. http://dx.doi.org/10.1038/s41590-024-01833-w.
Testo completoSpencer, David A., Mariya B. Shapiro, Nancy L. Haigwood e Ann J. Hessell. "Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic". Frontiers in Public Health 9 (26 maggio 2021). http://dx.doi.org/10.3389/fpubh.2021.690017.
Testo completoHsu, Denise C., John W. Mellors e Sandhya Vasan. "Can Broadly Neutralizing HIV-1 Antibodies Help Achieve an ART-Free Remission?" Frontiers in Immunology 12 (12 luglio 2021). http://dx.doi.org/10.3389/fimmu.2021.710044.
Testo completoHuang, Deli, Jenny Tuyet Tran, Alex Olson, Thomas Vollbrecht, Mary Tenuta, Mariia V. Guryleva, Roberta P. Fuller et al. "Vaccine elicitation of HIV broadly neutralizing antibodies from engineered B cells". Nature Communications 11, n. 1 (17 novembre 2020). http://dx.doi.org/10.1038/s41467-020-19650-8.
Testo completo